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ABSTRACT
Introduction: Peripheral intravenous cannula (PIVC)
insertion is one of the most common clinical
interventions performed in emergency care worldwide.
However, factors associated with successful PIVC
placement and maintenance are not well understood.
This study seeks to determine the predictors of first
time PIVC insertion success in emergency department
(ED) and identify the rationale for removal of the ED
inserted PIVC in patients admitted to the hospital ward.
Reducing failed insertion attempts and improving
peripheral intravenous cannulation practice could lead
to better staff and patient experiences, as well as
improving hospital efficiency.
Methods and analysis: We propose an
observational cohort study of PIVC insertions in a
patient population presenting to ED, with follow-up
observation of the PIVC in subsequent admissions to
the hospital ward. We will collect specific PIVC
observational data such as; clinician factors, patient
factors, device information and clinical practice
variables. Trained researchers will gather ED PIVC
insertion data to identify predictors of insertion
success. In those admitted from the ED, we will
determine the dwell time of the ED-inserted PIVC.
Multivariate regression analyses will be used to identify
factors associated with insertions success and PIVC
failure and standard statistical validation techniques will
be used to create and assess the effectiveness of a
clinical predication rule.
Ethics and dissemination: The findings of our
study will provide new evidence to improve insertion
success rates in the ED setting and identify strategies
to reduce premature device failure for patients admitted
to hospital wards. Results will unravel a complexity of
factors that contribute to unsuccessful PIVC attempts
such as patient and clinician factors along with the
products, technologies and infusates used.
Trial registration number: ACTRN12615000588594;
Pre-results.
BACKGROUND
Peripheral intravenous cannula (PIVC) inser-
tion is a vascular access clinical procedure
that is shared among many professionals,
including: nursing, medical, paramedical,
physician assistant, as well as technical and
support staff. Vascular Access Decisions in
the Emergency Room (VADER) or the emer-
gency department (ED) overwhelmingly
favour the PIVC as the device of choice. The
ubiquity of this procedure was demonstrated
in a point prevalence study undertaken in a
European hospital; over 84% of patients had
a vascular access device (VAD) of some type,
with 80% of these PIVCs.1 Factors identiﬁed
as predictors of insertion failure in the ED2 3
and premature device failure in admitted
patients are published separately.4 However,
notwithstanding literature concerning PIVCs
inserted in ED using ultrasound technology,5
none has focused on the survival of PIVC
from ED to hospital admission and this
represents a signiﬁcant gap in the literature.
Previously ﬁrst time insertion success in our
ED population was identiﬁed at 86%,
however one limitation was the use of a self-
report method.6 We subsequently performed
a chart review of this patient population
admitted with an ED placed PIVC so we
could identify a rationale for removal. We
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were unable to identify why the ED inserted PIVC is
removed with any great accuracy due to poor documen-
tation. We did however identify documented evidence of
repeat PIVCs within 72 h suggesting the ED PIVC is
failing to last 3 days. This subjects the patient to repeat
attempts. It is this prior work that has motivated this
observational study.
Insertion success
Preserving the venous anatomy from damage caused by
repeated skin punctures through failed PIVC insertion
attempts is a challenge in high-paced environments such
as the ED. Reducing the number of needle insertions
and skin punctures should become a priority for clinical
science. Moreover, reducing the number of inappropri-
ate PIVC insertions or those not clinically justiﬁed is
another priority.7 A reduction in repeated PIVC inser-
tions has been identiﬁed as a cost-saving strategy that
can save tens of millions of dollars for the Australian
healthcare service each year.8 Staff time to re-insert a
device, lost therapy time that impacts on treatment
options and an increase in length of stay, along with
additional products such as dedicated PIVC packs and
‘once only use’ equipment makes repeat attempts
expensive. So-called ‘ﬁrst time PIVC insertion success’
(where the inserter only pierces the skin once and suc-
cessfully places the PIVC in the vein) ranges from 65%
to 86% in the paediatric and adult populations.6 9–16
The variability of ﬁrst-time insertion success rates sug-
gests that PIVC insertion is frequently difﬁcult however
improved and sustained ﬁrst-time insertion success of
98–99% occurs when specialist insertion teams provide
PIVC insertion.17
Speciﬁc patient factors are reported to contribute to
insertion failure such as: age18; patient size3 5 6 19–28;
limited and suitable veins contributing to a difﬁcult
intravenous access3 19 22 27 29 30; previous history of
failed attempts and recent hospital admission12 30 31; dia-
betes2 19 27; intravenous drug use2 5 19–23 26 27; cancer
diagnosis and recent chemotherapy12 27 32; patient
anxiety (needle phobia).33 Additionally technologies
purported to enhance insertion success such as ultra-
sound or other vessel locating devices report ﬁrst-time
insertion success that ranges from 18% to 87%5 21 24 34
suggesting re-evaluation is required. However, clinician
factors such as experience of the inserter and number
of PIVC procedures performed6 9 10 12 32 35 contribute
to improved insertion success. Over 12 risk factors have
been reported to predict insertion failure in the emer-
gency care setting, these include: age, gender, race,
body mass index, history of chemotherapy, diabetes, dia-
lysis patients, intravenous drug abuse (IVDA), swelling,
non-visible veins, sickle cell disease and recent hospital-
isation or ED visit within 90 days.2 3 5 6 19–24 26–28 36–41
Improving the patient journey with better vascular
access care should be a priority for hospital
administrators.42
Post insertion complications
In the adult population, secondary data analysis from a
large randomised controlled trial indicate that post
insertion 25% of PIVCs fail.4 The causes of post inser-
tion failure warrant attention, and include; infection,
inﬁltration or extravasation, occlusion and dislodge-
ment, which can lead to a reduced therapeutic effect of
prescribed medicines.4 Post insertion failure is complex
multifactorial and is inﬂuenced by patient character-
istics, such as: age4 18; gender4; any infection at base-
line4; number and type of comorbidities43; smoking44;
and device characteristics such as: PIVC gauge and
length26 36 43; site of placement4 43; antibiotics pre-
scribed intravenous4; not using a J-loop or extension set
or closed system catheters45 46; securement device
failure47 and the hospital culture in managing these
medical devices, for example, the adoption of an aseptic
technique.48PIVC insertions in the ED have been
reported as a cause of phlebitis and Staphylococcus aureus
bacteraemia, leading to premature device failure. As a
result, routine PIVC replacement after 24 h is recom-
mended for ED PIVCs in an attempt to reduce the risk
of infection.49–51
Studies in the ED are limited to insertion failure and
risk factors for difﬁcult insertion.2 Those that do identify
dwell time during or post-ED are limited to PIVC inser-
tions using ultrasound-guided technology5 26 and 47%
of PIVCs inserted with ultrasound guidance failing
within 24 h.5 It is unknown how long the ED-inserted
PIVC (using traditional attempts) remains intravenous
and what the rationale for removal is. Added to this is
another unknown; that is, the number of repeat
attempts that occur after the removal of an ED PIVC.
Even when a dedicated intravenous team with a ﬁrst-
time insertion success rate of 98% perform the initial
insertion, the PIVC post insertion failure in an ortho-
paedic ward was 49% attributed to securement device
failure.47 The range of possible complications that have
been reported in the literature related to PIVCs are;
phlebitis/thrombophlebitis, psychological distress (needle
phobia), nerve injury, dislodgement (due to dressing
failure), occlusion, air embolism, tissue necrosis, inﬁltra-
tion/extravasation, infection and death.4 33 51–55
Such failures are unacceptable. These contribute to
increased length of hospital stay, thus interrupting the
patient care processes and clinical pathways.56
STUDY DESIGN
VADER is a prospective cohort study, which will observe
PIVC insertions at two EDs with a subsequent follow-up
of admitted patients to identify the dwell time of such
cannulae. The research aim of the VADER study is to;
(1) identify risk factors for peripheral intravenous can-
nulation success, (2) identify risk factors for reduced
dwell time/failure and (3) develop a clinical prediction
score for PIVC insertion in the ED.
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Participants and setting
The proposed study will be undertaken in the EDs of Sir
Charles Gairdner Hospital (SCGH) and Fiona Stanley
Hospital (FSH) Perth, Western Australia. Both EDs
provide 24 h emergency service for adult patients and
are accredited with the Australasian College for
Emergency Medicine for training. The departments
provide a full range of adult tertiary specialties.
According to the ED of SCGH information system over
33 228 PIVC insertion procedures were recorded
between July 2012 and June 2013 with over 64 000
patients registered. This is a substantial number of vascu-
lar access devices used by one department. FSH is a new
hospital campus and annual numbers of PIVC use are
unknown at present. Bed capacity at SCGH is 650, while
FSH has a capacity of 783.
Participants will include ED patients and ED clini-
cians. There are over 100 nurses and over 70 medical
doctors eligible to participate at each site.
Outcomes
Primary outcome
First-time insertion success is the primary outcome and
will be recorded as a dichotomous variable, either yes or
no. PIVC insertion failure is the outcome of interest for
analysis along with associated risk factors, which will be
identiﬁed using regression techniques.
Secondary outcome
A second statistical model is proposed to identify risk
factors for failure of the PIVC in patients admitted to
the wards. This will also be a dichotomous measure of
either yes or no.
Sampling framework
Sampling method
The sample population for this will proposed study
include patients that present to the ED and who subse-
quently require a PIVC. A convenience sampling
method will be used because of limited funding and
resources. An attempt will be made to gather all ED
patient presentation types and exclude none, thus redu-
cing sampling bias toward the inclusion of only difﬁcult
patients. An attempt will be made to gather all ED
patient presentation types and exclude none, thus redu-
cing sampling bias toward the inclusion of only difﬁcult
patients. All patients over the age of 18 years who
require the insertion of a PIVC and clinical staff, who
place PIVCs as part of their role in the ED, will be
included in the study. We will exclude patients who are
under 18 years of age and any clinician inserters who
decline to provide consent to be observed. A require-
ment of our ethical approval states we must consent clin-
icians before we observe their practice.
Sample size
Sample size calculations for this type of study are
complex57 and often the decision on how many
observations to record is really a pragmatic one. They
can be derived when there is one explanatory variable,
but, there is no agreed method to calculate sample sizes
when there are a number of explanatory variables pro-
posed in this study. As the primary outcome is ﬁrst-time
insertion success our sample size is calculated from a
previous clinical survey we performed resulting in a suc-
cessful ﬁrst attempt rate of 86%.6 With our proposed
sample size of 1000, we would have sufﬁcient numbers
to adequately investigate approximately 10 variables
using a multivariate logistic regression technique.
Additionally this number would be sufﬁcient based on
guidelines suggested by Peduzzi et al58 and Vittinghoff
and McCulloch.59 Furthermore, this would more than
adequately satisfy the minimum recommendation of
Steyerberg60 for validation purpose.
Data collection
This prospective study will be conducted when the inves-
tigator (PJC) or a small team of research nurses/assis-
tants are available during the time period June 2015—
December 2015. Data will be collected each day by the
investigator/research nurses/assistants trained in using
our case report form (CRF). They will prospectively
collect patient data and observe the PIVC insertion by
the ED clinician and record the ﬁrst-time insertion
success. In addition, the number and reason for any
clinicians to refuse to have an observation recorded will
be collected. Each morning, the unique medical
number of the previous days observations (which will be
stored and secured in a database on the hospital
network) will be identiﬁed for admission or discharge.
Patients who are discharged will contribute to our
planned risk factors for insertion success analysis.
Patients who are admitted will be followed up on the
ward daily and data collected until the PIVC that was
placed in the ED has been removed. This will assist iden-
tify the dwell time of the ED inserted PIVC and the
rationale for removal. The form includes demographic,
historical and clinical risk factors. The current literature
and clinical experts underpin our CRF, which contribute
to face and content validity of our CRF, respectively. We
have also assessed our CRF quantitatively using the
content validity index outlined by Pilot and Beck61 with
both ED clinicians and vascular access experts resulting
in excellent content validity. The developed CRF was
also used in our self-report study6 and proved to be
clear, logically ﬂowing, relevant and acceptable in the
ED clinical environment.
Proposed demographic and clinical data variables
Various variables will be collected to describe the patient
population that is not dissimilar to that found in the
majority of Australian adult emergency departments,
thus facilitating generalisability. These variables, evi-
denced to predict insertion failure and post insertion
failure are drawn from the literature. Some of the poten-
tial risk factors for insertion failure could conceivably be
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the same evaluated risk factors for post insertion failure,
with a small number of additional variables. We will use
a similar deﬁnitions for skin assessment quality62 and
vein assessment quality6 29 63 used in previous studies.
Insertion success will be deﬁned by the visible presence
of venous blood at the PIVC hub after the PIVC pierces
through the skin into a vein, in addition to a small
volume (up to 10 mL) of normal saline 0.9% connected
to the PIVC being ﬂushed into the vein without evi-
dence of any complication such as inﬁltration.
Validated questions and variables we intend to observe
and collect include; presenting complaint, weight status,
number of visible and/or palpable veins, vein size
(small 1 mm, medium 2–3 mm or large >4 mm); the
venous international assessment scale (VIA), skin type/
temperature (we will use a similar deﬁnitions for skin
assessment quality62 and vein assessment quality6 29 63
used in previous studies); skin shade; rationale for
insertion, prediction that the PIVC will be used for
intravenous therapy, clinician experience, clinician pre-
procedural estimation of success, aseptic technique;
number of needle redirections, additional products
used such as add on-devices referred to as needle-free
connectors and J-loops; use of ultrasound and any
observed blood spillage. Online supplementary appen-
dix 1 displays our CRF that will be used to collect our
observational data in ED.
The ward follow-up data to be collected will include
the rationale for PIVC removal and any factors based on
the aforementioned literature that inﬂuence failure.
Items included in the ward follow-up CRF contain addi-
tions and reﬁnements from a validated data collection
tool used in an international PIVC prevalence study.64
Data will be obtained from patient’s medical records,
patients and the healthcare professional allocated to
care for the admitted patient. We propose to obtain the
following information; PIVC removal time, patient dis-
charge time, routine replacement (72 h), intravenous
(IV) therapy completion; device failure rationale; dis-
lodgment (patient pulled it out, other patient factors
such as confusion, diaphoresis), dressing failure, patient
reported of pain, a peripheral venous access score
(PVAS) recommending replacement, occlusion (inability
to ﬂush PIVC), inﬁltration/extravasation, suspected
phlebitis/thrombophlebitis, suspected infection, hours
in situ, numbers of patient hours in hospital, number of
infusions or intravenous medicines prescribed, lost to
follow-up due to hospital transfer, subsequent PIVC
inserted, other vascular access device, venepuncture
(daily bloods) and type of intravenous medicine and/or
therapy see online supplementary appendix 2. Data will
be mapped with the census reporting any reportable
infection control episodes from PIVCs and with the hos-
pitals peripherally inserted central venous catheter data-
base. Attending clinicians will be made aware of any
cases where an infection is suspected in the ward
follow-up, so that a clinical assessment of the patient can
occur.
We will initially pilot our CRF so that the research
observers understand and accept any limitations that
may occur to ensure a standardised data collection
process. Inter-rater reliability between the research
observers will be performed to assess for congruency.
Planned statistical analysis
Univariate and multivariate binary logistic regression will
be conducted to determine the predictor variables of
ﬁrst-time insertion success. Variables that are signiﬁcant
at a 5% signiﬁcance level will be retained in the ﬁnal
model. Adjusted ORs and 95% CIs will be provided for
this ﬁnal model. A cross validation of the ﬁnal model
will be carried out by cross validating this model with a
hold out sample. Predictive performance of the vali-
dated prognostic model will be assessed by measures of
calibration and discrimination. Calibration refers to the
agreement between the observed probability and pre-
dicted probability of experiencing a successful ﬁrst-time
cannulation. We will categorise the predicted probabil-
ities into bins of equal width, and compare these to the
actual proportions successful in each of these bins
graphically by plotting observed proportions versus pre-
dicted probabilities. Measures of diagnostic perform-
ance, including sensitivity, speciﬁcity, positive and
negative predictive values, and positive and negative like-
lihood ratios for several probability thresholds will also
be used to assess model performance. The models
ability to distinguish between patients with a low prob-
ability and high probability of experiencing a successful
cannulation (ie, discrimination) will be assessed using
the C statistic. These can be compared to a predeter-
mined cut-off score to identify patients more likely to
have an unsuccessful attempt to allow for intervention in
a practical clinical setting. Analyses for secondary aims
will include Cox proportional hazards models and will
include; Time zero (T0): intravenous insertion, Time of
event (T1): PIVC failure, Time censored (T2): PIVC
removal or transfer to another hospital. Kaplan-Meier
curves will identify the survival time of ED inserted
PIVC.
Ethical considerations
A waiver of consent is granted for the inclusion of the
patients receiving a PIVC under section 2.3.10 of the
Australian national statement on ethical conduct in
human research. Patients who have the capacity to
understand will have a patient study ﬂyer read to them,
and therefore will have an option to decline the
researchers observe them receiving a PIVC insertion. In
adherence with the approved HREC conditions, clini-
cians will be consented by PJC or JR to allow the
research team to collect observational data using the
CRF; patient data will be obtained from the medical
record. The clinician performing the insertion will
provide informed consent for the duration of the study.
The clinician performing the insertion will provide
informed consent for the duration of the study. Each
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potential participant will receive a study information
guide and based on this will sign a consent form. No
coercion whatsoever will take place. The study is regis-
tered with the Australian New Zealand Clinical Trials
Registry ACTRN12615000588594.
DISCUSSION
The majority of acute patients that require a hospital
admission have a PIVC inserted in the ED.
Unfortunately, adult ﬁrst-time insertion success in emer-
gency settings vary considerably in range from 18% to
86%.3 6 12 15 34 A clinical prediction rule could conceiv-
ably reduce insertion failure and initiate a proactive
attempt. When traditional attempts are exhausted, com-
monly employed rescue techniques to ensure PIVC
insertion is through the use of ultrasound guidance.
However, even this method is not without its faults and
failure rates of ﬁrst-time insertion success range from
42% to 87%.14 46 Such results warrant further scrutiny as
the inclusion or referral criteria for an ultrasound
inserted PIVC is two or more failed traditional
attempts.40 65 66 Reducing failure with a clinical predic-
tion rule would improve patient experience, reduce
costs and improve ED processes and patient ﬂow.
Clinical prediction rule
Once the ﬁnal predictive model has been validated, pre-
dicted probabilities of successful ﬁrst-time cannulation
for new patients can be calculated based on the regres-
sion parameter estimates from this model. Previously
published PIVC insertion tools, rules and ﬂow charts
underpinned the development of our CRF15 67 however
none is speciﬁcally focused on ED insertion success and
avoidance of premature device failure. An observational
design is suggested by Adams and Leveson68 to establish
a clinical prediction rule. The results of this study will
develop a clinical prediction rule to establish proactive
PIVC insertion in the ED. This could, in theory, reduce
inappropriate PIVC placement, preserve patient veins
prior to any traditional attempts in favour of alternative
vascular access methods such as vessel locating devices
or the insertion of central venous access devices.
Additionally, a clinical prediction score could direct the
most appropriate trained clinician to insert a PIVC on
patients at greatest risk of failure. The number of
patients experiencing failed procedures, whether or not
they are painful suggests that clinicians need guidance
on how to improve the procedural aspects of PIVC inser-
tion. One study identiﬁes increases in patient pain when
multiple insertions are compared to one insertion
attempt.30
Equally as important as procedural success is the pre-
vention of post insertion PIVC failure. The dwell time
of PIVCs inserted with a traditional approach in the
ED is largely unknown. The latest evidence of PIVC
failure reports an excessive degree of post insertion
failure through inﬁltration, occlusion, phlebitis and
dislodgement, thus contributing to economic waste.4 69
Many of these failures may stem from suboptimal PIVC
insertion procedures and result in further waste and
pain for patients.
Strengths and limitations of this study
The strengths of this proposed work lie in the develop-
ment of our clinical CRF with international vascular
access experts and senior ED clinicians with excellent
content validity. One obvious limitation is that clinicians
may positively change their practice behaviour in the
presence of the researchers observing their perform-
ance. Alternatively it may have the opposite effect and
may inadvertently add extra stress and cause perform-
ance anxiety and therefore performance bias. However,
there is also another possibility, which is the potential of
the observed clinicians being used to working in a busy
ED environment where they are frequently observed by
patients, visitors, a variety of healthcare professional and
as a result not change practice behaviour at all. It is
unlikely we will obtain consent from all clinicians
employed in the ED for the duration of the study
period. Owing to the few resources we have we can only
use a convenience sample as opposed to a consecutive
sample and this may be perceived as a bias.
Conclusion
PIVCs are the most frequently inserted intravascular
device in the ED. Successful insertion requires the com-
bination of a small set of signiﬁcant procedural steps for
successful outcomes. Risk factors for PIVC failure have
been identiﬁed in large prospective studies,4 70 and pre-
vention of PIVC insertion failure with the use of special-
ist teams is growing,17 a greater focus needs to address
how to implement this knowledge with observational
data speciﬁc to the ED setting. Reducing the number of
unsuccessful PIVC insertion attempts should become a
priority for all EDs given the impact on patient out-
comes, clinical outcomes and cost implications. This
could improve the journey of patients with ED-inserted
PIVCs and reduce the rates of insertion failure and post
insertion failure. Reducing failed insertion attempts and
improving insertion practice could lead to better staff
and patient experiences, as well as greater hospital efﬁ-
ciency by using staff time and equipment effectively. This
proposed study seeks to address this gap in our knowl-
edge of how to reduce PIVC insertions, improve ﬁrst-
time insertion success and decrease premature failure of
the PIVC. Additionally our study could promote appro-
priate decision-making, for example, the appropriateness
of PIVC insertion in ED. This is a timely issue in light of
the choosing wisely campaign in Australia, which
attempts to reduce unnecessary waste in healthcare.
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